Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
03/27/1996 | EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby |
03/27/1996 | EP0702716A1 Ribozyme gene therapy for hiv infection and aids |
03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
03/27/1996 | EP0702561A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
03/27/1996 | CN1119459A Process for preparing cancer vaccines |
03/27/1996 | CN1119457A Bone stimulating factor |
03/27/1996 | CN1119406A Mucosal competitive exclusion flora |
03/27/1996 | CN1119112A Chinese drug 'Lishuiling capsule' for curing hydrops and preparing process |
03/27/1996 | CN1119109A Chinese medicine Longyang capsule for tonifying kidney and strengthening yang |
03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
03/26/1996 | US5502077 Fatty acid composition |
03/26/1996 | CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues |
03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
03/21/1996 | WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
03/21/1996 | WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
03/21/1996 | WO1996008261A1 Probiotic compositions |
03/21/1996 | DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor |
03/21/1996 | CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein |
03/21/1996 | CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
03/20/1996 | EP0702084A1 Recombinant retroviruses |
03/20/1996 | EP0701839A2 Therapeutic products containing organic ashes emitting 'far' infrared radiation |
03/20/1996 | EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell |
03/20/1996 | EP0701604A1 Immortalization of denditric cells with v-myc oncogene |
03/20/1996 | EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host |
03/20/1996 | EP0701455A1 Plasma-like solution |
03/20/1996 | EP0701450A1 Recombinant viruses and their use in gene therapy |
03/20/1996 | EP0489072B1 Treatment of chronic inflammatory conditions |
03/20/1996 | CN1118690A Pills replenishing bone marrow |
03/20/1996 | CN1031316C A container for receiving and separating a fluid, preferably blood plasma, into its ingredients |
03/19/1996 | US5500359 Fermentation, antitumor agents |
03/19/1996 | CA2073012C Method for isolating factor viii |
03/19/1996 | CA1338170C Ab-011 antibiotics and process for producing them |
03/19/1996 | CA1338169C Compounds wf 2015 a and b, production thereof and use thereof |
03/19/1996 | CA1338168C Antibiotic ll-e19020 alpha and beta |
03/14/1996 | WO1996007915A1 Predictive test for hepatitis-b resistance |
03/14/1996 | WO1996007748A1 Non self-inactivating, expression targeted retroviral vectors |
03/14/1996 | WO1996007747A1 Retroviral vector hybrids and the use thereof for gene transfer |
03/14/1996 | WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | WO1996007318A1 Buffer system for increasing seroconversion efficiency |
03/14/1996 | DE4441167C1 Prodn. of blood plasma as virus free dry granulate |
03/14/1996 | CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | CA2198707A1 Predictive test for hepatitis-b resistance |
03/13/1996 | EP0701130A2 Device and process for cell capture and recovery |
03/13/1996 | EP0700720A1 Plastic articles of reduced gas transmission and method therefor |
03/13/1996 | EP0700523A1 Embryotoxic factors |
03/13/1996 | EP0700430A1 Methods for selectively stimulating proliferation of t cells |
03/13/1996 | EP0700429A1 Retinal pigment epithelium transplantation |
03/13/1996 | EP0700300A1 Purification of plasma proteins |
03/13/1996 | EP0700299A1 Oxygen-reduced aqueous solution of factor viii |
03/13/1996 | EP0700297A1 Surrogate tolerogenesis for the development of tolerance to xenografts |
03/13/1996 | EP0514527B1 Chlorinated eta alumina-based catalyst and its use in isomerisation of c4-c6 n-paraffins |
03/13/1996 | EP0506817B1 Pharmaceutical preparation for controlling pathogenic intestinal bacteria |
03/13/1996 | EP0497929B1 Composition for stabilizing blood plasma during pasteurization |
03/13/1996 | CN1118574A Immunotherapeutic composition |
03/13/1996 | CN1118259A Medicine for stomach diseases |
03/13/1996 | CN1118258A Preparation of brain-care pill |
03/13/1996 | CN1118257A Extraction of metabolite from bacterial liquid |
03/13/1996 | CN1118256A Preparation of chicken embryo nutrient liquid and instant drink |
03/07/1996 | WO1996007097A1 Cell separation apparatus and method |
03/07/1996 | WO1996006943A1 Cell cycle regulated repressor and dna element |
03/07/1996 | WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
03/07/1996 | WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
03/07/1996 | WO1996006929A2 Rapid expansion method ('rem') for in vitro propagation of t lymphocytes |
03/07/1996 | WO1996006928A1 A method of selecting pluripotent hematopoietic progenitor cells |
03/07/1996 | WO1996006859A1 Trophic factors for central nervous system regeneration |
03/07/1996 | WO1996006642A1 Allogeneic and xenogeneic transplantation |
03/07/1996 | WO1996006640A1 Bioadhesive-wound healing composition |
03/07/1996 | WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
03/07/1996 | WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy |
03/07/1996 | CA2198891A1 Genetically modified t cells |
03/07/1996 | CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
03/07/1996 | CA2198587A1 Trophic factors for central nervous system regeneration |
03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
03/07/1996 | CA2194876A1 Bioadhesive-wound healing composition |
03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
03/06/1996 | EP0699682A1 Process for the preparation and/or purification of clavulanic acid |
03/06/1996 | EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
03/06/1996 | EP0699441A1 Agent for the treatment of atopic eczema and process for the preparation thereof |
03/06/1996 | EP0699432A1 Cosmetic and/or dermatologic composition containing thermal or mineral water and an active agent against acnee or ageing |
03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
03/06/1996 | EP0699235A1 Animal model for hepatitis virus infection |
03/06/1996 | EP0699210A1 Topical fibrinogen complex |
03/06/1996 | EP0699073A1 Allogeneic and xenogeneic transplantation |
03/06/1996 | EP0528949B1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
03/06/1996 | CN1117883A Dizzy-protective gauze mask and its making method |
03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
03/06/1996 | CN1117872A Health-care medicinal liquor |
03/06/1996 | CN1117871A Chinese medicinal tonic tea made from bear gall and preparation method thereof |
03/06/1996 | CN1117867A Medicine for prevention and treatment of iodine-deficient disease and preparation method thereof |
03/06/1996 | CN1117866A Chinese proprietary medicine for caring headache and trigeminal neuralgia |
03/06/1996 | CN1117865A "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy |